PDLIM2 and cancer: Although it dramatically increases TILs as well (Sun et al., 2019), chemotherapy also induced the expression of PD-L1 on cancer cells (Figure 6A), which presumably protects cancer cells from immune attack and thereby restricts further efficacy improvement of its combination with PDLIM2 nanotherapy.